SlideShare a Scribd company logo
1
PRESENTED BY
DR ASIF K
DEPARTMENT OF PERIODONTICS
 Offenbacher 1996 defines periodontal medicine as a
rapidly emerging branch of periodontology which
focuses on the research of new data establishing a
strong relationship between periodontal health or
disease and systemic health or disease.
2
 This means a two-way relationship in which periodontal disease in
an individual may have a powerful influence on an individual’s
systemic health or disease .
 Non specific accumulation of bacterial plaque was once thought to
be the cause of periodontal destruction, but now it is recognised
that periodontitis is an infectious disease associated with
predominantly gram negative bacteria.
 Although pathogenic bacteria are necessary for periodontal
disease, they are not sufficient alone to cause the disease. A
susceptible host is also required.
3
 There are many systemic conditions that can
modify the host susceptibility to periodontitis.
 Patients with immune suppression may not be able
to mount effective host response to subgingival
microorganisms, resulting in more rapid and severe
attachment loss.
4
 Although the potential impact of many systemic
conditions on the periodontium is well documented,
recent studies done by Seymour et al suggest that
periodontal infection may significantly enhance the risk
for certain systemic condition or alter the course of
systemic condition.
5
 Acc. To William Hunter in 1900,
◦ Oral microorganism- responsible for systemic
conditions
◦ Restoration instead of extraction, trapping of
infectious agents
◦ Gingivitis & periodontitis- foci of infection
Connection between oral sepsis & resulting systemic
condition could be shown by removal of causative sepsis
through extraction & observation of improvement in
systemic health
6
 This theory fell into disrepute in 1940’s & 1950’s
when widespread extraction failed to reduce or
eliminate the systemic conditions to which the
supposedly infected dentition has been linked.
7
 Cardiovascular/ cerebrovascular system
◦ Atherosclerosis
◦ Coronary heart disease (CHD)
◦ Angina
◦ Myocardial infarction (MI)
◦ Cerebrovascular accident (stroke)
 Endocrine system
◦ Diabetes mellitus
8
 Reproductive system
◦ Preterm low birth weight infants
◦ Preeclampsia
 Respiratory system
◦ Chronic obstructive pulmonary disease
◦ Acute bacterial pneumonia
9
 Well known relationship
 Study done by Matilla et al found that MI patients had significantly
worse dental health than did the controls.
 This association between poor dental health and MI was independent
of the known risk factor for heart disease such as age, hypertension,
chlosterol levels, diabetes.
 Malthaner et al also found an increased risk of angiographically
defined CAD in subjects showing greater attachment and bone loss.
 However after adjusting for other risk factor for the CAD the
relationship between the periodontal status and CAD was no longer
significant.
10
 Associated with atherogenesis & thrombogenesis
11
 Increased viscosity of blood → increase risk of
thrombus formation → ischemic heart disease &
cerebrovascular accident
 Factors affecting blood viscosity
◦ Plasma fibrinogen
◦ Plasma lipoproteins
◦ White blood cell count
◦ von Willebrand factor
◦ Increased plasma fibrinigen level is considered as
risk factor for cardiovascular disease (Lowe et al).
12
Systemic or periodontal infection
↑ Fibrinogen, ↑ White blood cell count
↑ von Willebrand factor
↑ Blood viscosity
Ischemic heart disease
13
Thrombogenesis
14
 Platelet aggregation plays a major role in
thrombogenesis .
 Most cases of acute myocardial
precipitated by thromboembolism
 Oral organisms may be involved
thrombogenesis
infarction are
in coronary
Thromboembolism mechanism
15
Platelet binds – Streptococcus sanguis and P. gingivalis
↓
Platelet aggregation – Plalelet Aggregation Associated
Protein
↓
Bacterial strains enters the circulation
↓
Forms thromboemboli
↓
Cardiac & pulmonary changes
 It is a focal thickening of the arterial intima , the
innermost layer lining the lumen of the vessel , and
the arterial media, the thick layer under the arterial
intima consisting of smooth muscle, collagen, and
elastic fibres.
 Occur in large & medium sized elastic & muscular
arteries
 Intimal lesion is called atheroma or atheromatous or
fibro fatty plaques
 Protrude into & obstruct vascular lumina
16
 Periodontitis & atherosclerosis have many potential
pathogenic mechanism in common
 Both have
Complex causation
Genetic & gender predisposition
Share many risk factors, most significant is
smoking status
 Periodontitis, which is a chronic inflammation
initiated by microbial plaque can predispose to
atherosclerosis.
17
LPS released from microorganisms within the
periodontal pocket- enter the diseased
periodontium.
Monocytes/ Macrophages adheres vascular
endothelium
Ingest circulating LDL & forms foam cell –
atheromatous plaque
Smooth muscle & collagen proliferation – arterial
wall thickening
Narrows lumen & ↓blood flow
18
Figure showing pathogenesis of atherosclerosis
19
Periodontal infection
Gram- negative bacteremia/ LPS
Endothelial damage,
Platelet adhesion/ aggregation
Monocyte infiltration/ proliferation
Cytokine/ growth factor production
Thrombus formation
Atheroma formation
Vessel wall thickening
Thromboembolic events
20
21
1. Direct effects of infectious agents in atheroma
formation
2. Indirect or host mediated effects triggered by
infection
3. Common genetic predisposition for periodontal
disease & atherosclerosis
4. Common risk factors such as life style
 Direct effects of infectious agents in
atheroma formation
Studies done by Tonetti M et al, 2007 show
Porphyromonas gingivalis is found in carotid and
coronary atheromas.
Deshpande and colleagues (1998) conducted a
study and concluded that P. gingivalis can invade
and may proliferate in the endothelial cells
Herzberg and Meyer (1996) showing that P.
gingivalis is able to induce aggregation of
platelets, which is thought to be associated with
thrombus formation.
Indirect
infection
or host mediated effects triggered by
Periodontitis induces an inflammatory response,
production of acute-phase proteins, such as C-reactive
protein and fibrinogen. C-reactive protein and
fibrinogen are independent risk factors for coronary
artery disease, hence if they are induced by
periodontal infection, this may help explain the link
between periodontal disease and heart disease.
 A recent study by Wu and colleagues (1999) using the
NHANES III database, found that C-reactive protein and
plasma fibrinogen were related to poor periodontal health,
which provides support for this hypothesis.
Common genetic predisposition for periodontal
disease & atherosclerosis
Beck JD and colleagues (1996) have provided
a model proposing that there is a genetically
determined hyper inflammatory macrophage
phenotype in periodontal disease, which
for
contributes to the susceptibility
atherosclerosis
Potential linkage mechanisms for periodontal disease &
myocardial infarction
Evidence for the role of inflammatory mediators
C-reactive protein (CRP)
Smooth muscle cells proximal to apoptotic cells in the
arterial plaque produce secretory type II phospholipase
which interacts with inverted phospholipid bilayer in the
membrane of an apoptotic cell, thus preparing a nidus for
CRP to bind.
CRP induces local proinflammatory cytokine production &
may bind complement either prior to tissue localisation or
in situ, thereby enhancing removal of dying cell.
Complement activation in turn may precipitate collateral
damage.
27
Tumor Necrosis Factor-α
TNF-α has been shown to increase the synthesis of
triglycerides in the liver and to inhibit lipoprotein
lipase.
This elevated levels of triglyceride rich
glycoproteins and decreased levels of high density
lipoprotein cholesterol has been associated with
coronary heart disease.
Also macrophages and smooth muscle cells
expressing TNF –α are present in atherosclerotic
plaques, suggesting its role in atherogenesis.
28
Fibrinogen
29
•Fibrinogen is an acute phase protein mainly
synthesized in the liver in response to IL-6.
•Fibrinogen levels increase during infections and
inflammatory conditions including Periodontitis.
•IL-1 is considered as one of the important mediators
in the pathogenesis of periodontal disease and both
fibrinogen and fibrin can stimulate production of IL-1β
and protein by binding to CD18 integrin receptors on
normal human monocytes.
ICAM-1 and VCAM-1
30
molecule-1(ICAM-1) and
Intercellular adhesion
vascular cell adhesion molecule-1 (VCAM-1) are
important in the firm endothelial cell attachment and
transendothelial migration of leucocytes, thus
playing a central role in leucocyte recruitment and
their function in inflammatory reactions.
These molecules act as modulators of cell to cell
interactions as activators of certain target cells and
possibly, even as neutrophil chemoattractants. These
soluble factors have been associated with various
inflammatory conditions.
Presence of systemic infection before stroke
↓
Greater ischemia & more severe post ischemic
neurologic defect.
Stroke patients with a preceding infection had a slightly
higher levels of plasma fibrinogen & CRP than thosewithout
infection
31
 Syrjagen et al 1989, found a statistically significant poor level of
oral health in patients with ischemic cerebral infarction as
compared to controls.
 Grau & colleagues 1997, reported that poor dental status was
associated with cerebral ischemia.
 Beck & colleagues 1996, provided first longitudinal data relating
stroke to oral infections. They found that high mean alveolar bone
loss was predictive of subsequent stroke.
32
 Complex metabolic disorder characterised by chronic
hyperglycemia.
 Diminished insulin secretion, impaired insulin action or
a combination of both result in the inability of
glucose to be transported from the bloodstream into
the tissues which in turn results in high blood glucose
level.
 Alteration in lipid or protein metabolism
33
1. Type 1 diabetes (insulin dependent)
2. Type 2 diabetes (non insulin dependent)
3. Gestational diabetes
4. Others
◦ Genetic defects in beta cell function
◦ Genetic defects in insulin action
34
Food digestion
↓
↑ blood glucose
↓
↑ Insulin secretion
↓
 Muscle increases uptake of glucose
 Muscle & liver store glucose as glycogen
 Liver prevents glycogen from breaking down into glucose
↓
↓ blood glucose
35
Type 1 diabetes Type 2 diabetes
Age of onset Generally < 30 years Generally in adult hood
Most common body type Thin or normal stature Obese
Race White African American,
American Indian
Family history Common More common
Rapidity of clinical onset Abrupt Slow
Pathogenesis Autoimmune beta cell
destruction
Insulin resistance, impaired
insulin secretion, increased
liver glucose production
Endogenous insulin
production
None Decreased, normal or
elevated
Susceptibility to
ketoacidosis
High Low
Treatment may include Diet, exercise, insulin Diet, exercise, oral agents,
insulin
36
 It is clear from epidemiologic research that diabetes
increases risk for & severity of periodontal disease.
 The increased prevalence and severity of
periodontitis typically seen in patients with diabetes,
especially those with poor metabolic control led to
the designation of periodontal disease as sixth
complication of diabetes (Loe et al ).
37
 Complications of diabetes
mellitus
1. Retinopathy
2. Nephropathy
3. Neuropathy
4. Macrovascular
disease
5. Altered wound
healing
6. Periodontal disease
38
 Taylor et al conducted a study amongst type 2 diabetes
patients and concluded that severe periodontitis was
associated with significant worsening of the glycemic control
over time.
 He concluded that individual with severe periodontitis at
baseline examination were associated with a greater
incidence of worsening glycemic control over a period of 2 to
4 years as compared to those without periodontitis at
baseline examination.
 Macrovascular complications were also found to be more
amongst individual with severe periodontitis at baseline.
39
 In diabetic patients with periodontitis, periodontal therapy
may have beneficial effect on glycemic control.
 This is true for patients with with relatively poor glycemic
control and advanced periodontal destruction before
treatment.
 Hiltunen et al conducted a study amongst 65 subjects with
type 1 diabetes and chronic periodontitis and found that
although there was overall improvement in periodontal health
after therapy , 35 % of subjects had an improvement in
glycemic control after therapy, 37 % had no significant
change and 28 % showed worsening of glycemic control.
40
Effectsof periodontalinfection on glycemia
41
•Bacterial infections decrease insulin-mediated glucose
uptake by skeletal muscle and produce whole-body insulin
resistance.
•Acute endotoxemia and cytokine production, mostly
TNF-α and IL-lß, induce insulin resistance and decreased
insulin action.
•The insulin receptor tyrosine kinase, and the action of
protein kinase C may, either individually or in combination,
mediate some of the insulin effects such as translocation
and activation of glucose-transporting proteins.
•TNF-α has been suggested as the mediator of
insulin resistance in infection by suppressing insulin
induced tyrosine phosphorylation of insulin receptor
substrate-1 (IRS-1), thus impairing insulin action.
42
Gram- negative
periodontal
infection
Increased
insulin
resistance
Worsened
glycemic
control
43
Periodontal
treatment
Improved
insulin
sensitivity
Improved
glycemic
control
Decreased inflammation
44
 Treatment with scaling & root planing, surgery,
selected tooth extraction & systemic antibiotics
resulted in decreased insulin demand.
 Miller et al 1992, evaluated that scaling & root
planing combined with systemic doxycycline therapy
for 2 weeks, when given in type I diabetic patients
with improved periodontal health also had significant
improvement in glycemic control.
45
 Tetracycline can also be given as tetracycline is known to
suppress glycation of proteins & to decrease activity of
tissue- degrading enzymes such as MMPs.
 Diabetes is associated with greatly elevated production of
collagenase, low dose doxycycline has been used in
treatment of periodontitis in diabetic subjects.
 Al-Ghazi et al 2003 & Engerbretson et al 2003,
reported short term improvements in glycemic control
with combination therapy, whereas no change was seen
with mechanical therapy alone.
46
 The international definition of low birth weight
adopted by the Twenty-ninth World Health Assembly
in 1976 is a birth weight of ‘‘less than 2500 g’’
 Low birth weight can be as a result of both a short
gestational period and retarded intrauterine growth.
47
 Causes
◦ Preterm labor or premature rupture of membranes
◦ Smoking, alcohol or drugs use during pregnancy
◦ Inadequate prenatal care
◦ Race, low socioeconomic status
◦ Hypertension, diabetes
◦ High or low maternal age
◦ Genitourinary tract infection
◦ Maternal stress & genetic background
◦ Periodontal disease
48
 Labor is characterized by coordinated uterine
contractions leading to cervical dilatation, and finally
expulsion of the fetus.
 In term (‘‘normal’’) labor, rupture of the membranes
occurs after initiation of contractions.
49
•The earliest identified events in labor are increases in
the bioavailability of prostaglandin E2, and in the
concentration of receptors for the hormone oxytocin.
•The increase in oxytocin receptors during labor induces
the stretching of the cervix and myometrium which is
thought to initiate a neurogenic reflex to the
neurohypophysis of the pituitary gland, which acts as
positive feedback for oxytocin production.
50
 Remote gram- negative infection may play a role in
LBW infants
 Periodontopathic organisms & their products may
mediate host cytokine production in target tissues.
 Collins et al 1994, reported that P.gingivalis during
gestation causes significant increase in TNF- a &
PGE2.
51
 Significant correlation between both TNF- a & PGE2
levels, as well as fetal death & growth retardation.
 Collins et al also evaluated that there was
decreased fetal birth weight & increased fetal death
after intravenous injections with LPS derived from
P.gingivalis.
 Offenbacher et al 1996 found that women having
LBW infants had greater clinical attachment loss
than women having NBW infants.
52
 In a cross sectional study, women having LBW infants
had significantly higher levels of A.A, Bacteroides
forsythus, P. gingivalis and Treponema denticola in
their subgingival plaque.
 Lopez et al 2002 found that women who received
SRP before 28 weeks of gestation, followed by
prophylaxis every 2 weeks until parturition, had a
LBW rate of 1.8% as compare to women who did not
receive periodontal therapy who had LBW rate of
10.1%
53
•Periodontal infections, serve as reservoirs for Gram-
negative anaerobic organisms, lipopolysaccharide (LPS,
endotoxin), and inflammatory mediators.
•Exposure to oral LPS down-regulates E-selectin
expression on endothelial cells and thereby prevents the
normal leukocytic margination and diapedesis which would
occur in response to a secondary enteric LPS challenge.
•This raises the possibility that systemic challenge with
oral LPS may inhibit normal neutrophil clearance of
enteric organisms that may permit a selective
overgrowth or invasion of Gram-negative organism within
the genitourinary tract. including PGE2 and TNF-α, may
pose a potential threat to the fetal-placental unit.
54
BacterialVaginosis
55
Caused by changes in the vaginal microflora in which
normally predominant facultative lactobacilli are
replaced by Gardnerella vaginalis; anaerobic
organisms, including species of the genera Prevotella,
Bacteroides, Peptostreptococcus, Porphyromonas,
and others.
Bacterial vaginosis is a known risk factor for
preterm labor, premature rupture of membranes, and
LBW.
.
The primary mechanism has traditionally been thought
to be ascending infection from the vagina and
endocervix.
Endotoxin & bioactive enzymes by many organisms
associated with vaginosis may directly injure tissue, as
well as induce release of proinflammatory cytokines
and prostaglandins.
56
•Throughout normal gestation, amniotic prostaglandin levels
rise steadily until a sufficient threshold is reached that
induces labor and delivery.
•Maternal infection may cause increased prostaglandin
production and may result in labor- inducing levels being
•achieved before full gestation
•Various pro-inflammatory cytokines such as IL-1, IL-6, and
TNF α have been found in the amniotic fluid of women with
preterm labor.
•Women with preterm labor often have culture-positive
amniotic fluid, even in the absence of clinical infection. Of
culture-positive patients, the most commonly isolated
species is Fusobacterium nucleatum.
57
 Airflow obstruction resulting from chronic bronchitis
or emphysema.
 Bronchial mucosal gland enlarge & inflammatory
process occurs in which neutrophils & mononuclear
inflammatory cells accumulate within the lung tissue.
58
 Risk factors of COPD
◦ Cigarette smoking
◦ Genetic conditions
 Presence of defective alpha-1 antitrypsin
 Variant alpha-1 antichymotyrpsin
 Alpha-2 macroglobulin
 Vitamin D- binding protein
59
 Share similar pathogenic process
 Host inflammatory response mounted in response to
chronic challenge
◦ By bacteria in periodontal disease
◦ By factors like cigarette smoke in COPD
 Neutrophil influx → release of oxidative & hydrolytic
enzymes → tissue destruction directly.
60
 Recruitment of monocytes & macrophages leads to
further release of proinflammatory cytokines.
 Hayes et al (1998) found a positive correlation
between advanced alveolar bone loss and COPD.
 Scannapieco et al 1998, individuals with poor oral
hygiene have been found to be at increased risk for
chronic respiratory diseases such as bronchitis &
emphysema.
61
 Infection of the lungs caused by
Bacteria
Viruses
Fungi
Mycoplasma
62
Pneumonia
Community
acquired
Hospital
acquired
63
 Caused by
◦ Inhalation of infectious aerosol
◦ Aspiration of oropharyngeal organism
 Streptococcus pneumoniae & H.influenzae
 Antibiotic therapy is highly successful in resolution
of the cases of community acquired pneumonia.
 Till now no association between periodontal disease &
community acquired pneumonia has been found
64
 Nosocomial pneumonia
 Gram- negative aerobic organism
 Many cases by anaerobic bacteria, subgingival
environment
 It is usually caused by the aspiration of
oropharyngeal contents, potential respiratory
pathogens (PRPs)
65
 Selective decontamination to eradicate PRPs- systemic
antibiotics + orally administered nonabsorbable antibiotics
 PRPs may also originate in oral cavity, dental plaque serve
as a reservoir
 Subgingival plaque harbor PRPs & periodontal pathogens,
associated with nosocomial pneumonia.
66
 Furthermore, anaerobic
pocket may serve as
respiratory diseases.
organisms from
a inoculum for
periodontal
suppurative
 Scannapieco et al 2003, concluded that
interventions used to improve oral hygiene, such as
mechanical tooth brushing & chemical antimicrobials
rinses, have a potential to decrease the risk of
nosocomial pneumonia in high-risk patients, such as
those in intensive care units or those on ventilators.
67
1. Oral pathogens may be aspirated into lung to cause
infection
2. Periodontal disease- associated enzymes in saliva may
modify mucosal surfaces to promote adhesion &
colonization by respiratory pathogens
3. Periodontal disease- associated enzymes may destroy
salivary pellicles on pathogenic bacteria
4. Cytokines originating from periodontal tissues may alter
respiratory epithelium to promote infection by
respiratory pathogens
68
 Periodontal disease may affect the host’s susceptibility to
systemic disease through subgingival biofilms, acting as
reservoirs of Gram negative bacteria, transient
bacteremia, release of microbial toxins & as a reservoir of
inflammatory mediators.
 More research is needed to these systemic diseases, &
then develop appropriate interventions
 More research is needed before recommendations can be
made to treat periodontal disease as a strategy to prevent
or treat CVD, diabetes mellitus, pre-term birth & other
adverse pregnancy outcomes & also respiratory diseases.
70
Periodontal medicine.pptx

More Related Content

What's hot

Host microbial interaction in periodontal disease
Host microbial interaction in periodontal diseaseHost microbial interaction in periodontal disease
Host microbial interaction in periodontal disease
Anushri Gupta
 
Nutrition and periodontium
Nutrition and periodontiumNutrition and periodontium
Nutrition and periodontium
Kapil Arora
 
Interdisciplinary periodontics
Interdisciplinary periodonticsInterdisciplinary periodontics
Interdisciplinary periodontics
Dr Sreelakshmi
 
Host microbial interactions in periodontal diseases
Host microbial interactions in periodontal diseasesHost microbial interactions in periodontal diseases
Host microbial interactions in periodontal diseases
Dr Heena Sharma
 
Peridontium and sex hormones
Peridontium  and sex hormonesPeridontium  and sex hormones
STEM CELLS IN PERIODONTICS
STEM CELLS IN PERIODONTICSSTEM CELLS IN PERIODONTICS
STEM CELLS IN PERIODONTICS
Prajakta Phadke
 
Periodontal vaccines
Periodontal vaccinesPeriodontal vaccines
Periodontal vaccines
Hudson Jonathan
 
The role of gingipains in the pathogenesis of periodontal diseases
The role of gingipains in the pathogenesis of periodontal diseasesThe role of gingipains in the pathogenesis of periodontal diseases
The role of gingipains in the pathogenesis of periodontal diseases
Ankita Jain
 
Host modulation therapy
Host modulation therapyHost modulation therapy
Host modulation therapy
Vijay Apparaju
 
Journal Club Periodontics
Journal Club PeriodonticsJournal Club Periodontics
Journal Club Periodontics
Dr John Kazim
 
Porphyromonas gingivalis - Dr Harshavardhan Patwal
Porphyromonas gingivalis - Dr Harshavardhan PatwalPorphyromonas gingivalis - Dr Harshavardhan Patwal
Porphyromonas gingivalis - Dr Harshavardhan Patwal
Dr Harshavardhan Patwal
 
ROLE OF VIRUSES IN PERIODONTAL DISEASES
ROLE OF VIRUSES IN  PERIODONTAL DISEASESROLE OF VIRUSES IN  PERIODONTAL DISEASES
ROLE OF VIRUSES IN PERIODONTAL DISEASES
Dr Ripunjay Tripathi
 
Desquamative gingivitis ppt
Desquamative gingivitis pptDesquamative gingivitis ppt
Desquamative gingivitis ppt
ShrutiPatil123
 
Novel non surgical periodontal approaches
Novel non surgical periodontal approachesNovel non surgical periodontal approaches
Novel non surgical periodontal approaches
Dr. vasavi reddy
 
Host modulation therapy
Host modulation therapyHost modulation therapy
Host modulation therapy
Dr Heena Sharma
 
MICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASES
MICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASESMICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASES
MICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASES
Syed Dhasthaheer
 
p.gingivalis
p.gingivalisp.gingivalis
p.gingivalis
Mehul Shinde
 
Innate immunity in periodontics
Innate immunity in periodonticsInnate immunity in periodontics
Innate immunity in periodontics
Sheethalan Ravi
 
Host microbe interaction in periodontal disease
Host microbe interaction in periodontal diseaseHost microbe interaction in periodontal disease
Host microbe interaction in periodontal disease
Dr Saif khan
 
Controversies in periodontics
Controversies in periodonticsControversies in periodontics
Controversies in periodontics
R Viswa Chandra
 

What's hot (20)

Host microbial interaction in periodontal disease
Host microbial interaction in periodontal diseaseHost microbial interaction in periodontal disease
Host microbial interaction in periodontal disease
 
Nutrition and periodontium
Nutrition and periodontiumNutrition and periodontium
Nutrition and periodontium
 
Interdisciplinary periodontics
Interdisciplinary periodonticsInterdisciplinary periodontics
Interdisciplinary periodontics
 
Host microbial interactions in periodontal diseases
Host microbial interactions in periodontal diseasesHost microbial interactions in periodontal diseases
Host microbial interactions in periodontal diseases
 
Peridontium and sex hormones
Peridontium  and sex hormonesPeridontium  and sex hormones
Peridontium and sex hormones
 
STEM CELLS IN PERIODONTICS
STEM CELLS IN PERIODONTICSSTEM CELLS IN PERIODONTICS
STEM CELLS IN PERIODONTICS
 
Periodontal vaccines
Periodontal vaccinesPeriodontal vaccines
Periodontal vaccines
 
The role of gingipains in the pathogenesis of periodontal diseases
The role of gingipains in the pathogenesis of periodontal diseasesThe role of gingipains in the pathogenesis of periodontal diseases
The role of gingipains in the pathogenesis of periodontal diseases
 
Host modulation therapy
Host modulation therapyHost modulation therapy
Host modulation therapy
 
Journal Club Periodontics
Journal Club PeriodonticsJournal Club Periodontics
Journal Club Periodontics
 
Porphyromonas gingivalis - Dr Harshavardhan Patwal
Porphyromonas gingivalis - Dr Harshavardhan PatwalPorphyromonas gingivalis - Dr Harshavardhan Patwal
Porphyromonas gingivalis - Dr Harshavardhan Patwal
 
ROLE OF VIRUSES IN PERIODONTAL DISEASES
ROLE OF VIRUSES IN  PERIODONTAL DISEASESROLE OF VIRUSES IN  PERIODONTAL DISEASES
ROLE OF VIRUSES IN PERIODONTAL DISEASES
 
Desquamative gingivitis ppt
Desquamative gingivitis pptDesquamative gingivitis ppt
Desquamative gingivitis ppt
 
Novel non surgical periodontal approaches
Novel non surgical periodontal approachesNovel non surgical periodontal approaches
Novel non surgical periodontal approaches
 
Host modulation therapy
Host modulation therapyHost modulation therapy
Host modulation therapy
 
MICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASES
MICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASESMICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASES
MICROBIAL SPECIFICITY WITH RESPECT TO PERIODONTAL DISEASES
 
p.gingivalis
p.gingivalisp.gingivalis
p.gingivalis
 
Innate immunity in periodontics
Innate immunity in periodonticsInnate immunity in periodontics
Innate immunity in periodontics
 
Host microbe interaction in periodontal disease
Host microbe interaction in periodontal diseaseHost microbe interaction in periodontal disease
Host microbe interaction in periodontal disease
 
Controversies in periodontics
Controversies in periodonticsControversies in periodontics
Controversies in periodontics
 

Similar to Periodontal medicine.pptx

gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...
gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...
gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...
arunperio
 
Periodontal medicine
Periodontal medicinePeriodontal medicine
Periodontal medicine
Navneet Randhawa
 
DOC-20221116-WA0009..pptx
DOC-20221116-WA0009..pptxDOC-20221116-WA0009..pptx
DOC-20221116-WA0009..pptx
MeghnaNigam1
 
periodontal medicine.pptx
periodontal medicine.pptxperiodontal medicine.pptx
periodontal medicine.pptx
veena621629
 
PERIODONTAL MEDICINE 1.pptx DIABETES DIABE
PERIODONTAL MEDICINE 1.pptx DIABETES DIABEPERIODONTAL MEDICINE 1.pptx DIABETES DIABE
PERIODONTAL MEDICINE 1.pptx DIABETES DIABE
Nitika588942
 
Periodontal Medicine: Impact of periodontal disease on systemic health
Periodontal Medicine: Impact of periodontal disease on systemic healthPeriodontal Medicine: Impact of periodontal disease on systemic health
Periodontal Medicine: Impact of periodontal disease on systemic health
Binaya Subedi
 
Systemic disease and periodontal health..pptx
Systemic disease and periodontal health..pptxSystemic disease and periodontal health..pptx
Systemic disease and periodontal health..pptx
Asawer Ahmed Fayyad
 
Coagulacion diseminada intravascular
Coagulacion diseminada intravascularCoagulacion diseminada intravascular
Coagulacion diseminada intravascularmrpienda
 
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdfALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
zaragalicia
 
Systemic Health and Periodontal Disease.pptx
Systemic Health and Periodontal Disease.pptxSystemic Health and Periodontal Disease.pptx
Systemic Health and Periodontal Disease.pptx
DrCarlosIICapitan
 
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptxPERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
Priyanka Pai
 
Current approach in periodontal care
Current approach in periodontal careCurrent approach in periodontal care
Current approach in periodontal care
ohdmoh
 
Periodontal diseases & cardiovascular system By Dr Sachin Rathod
Periodontal diseases & cardiovascular system By Dr Sachin RathodPeriodontal diseases & cardiovascular system By Dr Sachin Rathod
Periodontal diseases & cardiovascular system By Dr Sachin Rathod
Dr Sachin Rathod
 
ckd-23-1-1.pdf
ckd-23-1-1.pdfckd-23-1-1.pdf
ckd-23-1-1.pdf
Adamu Mohammad
 
2019 evolucion del estado de Sepsis en español.pdf
2019 evolucion del estado de Sepsis en español.pdf2019 evolucion del estado de Sepsis en español.pdf
2019 evolucion del estado de Sepsis en español.pdf
mayra555817
 
Nature ei
Nature   eiNature   ei
Nature ei
gisa_legal
 
periodontal medicine A two-way street relationship between periodontal diseas...
periodontal medicine A two-way street relationship between periodontal diseas...periodontal medicine A two-way street relationship between periodontal diseas...
periodontal medicine A two-way street relationship between periodontal diseas...
RashmitaNayak25
 
PERIODONTAL MEDICINE AN OVERVIEWPERIODONTAL MEDICINE AN OVERVIEW
PERIODONTAL MEDICINE  AN OVERVIEWPERIODONTAL MEDICINE  AN OVERVIEWPERIODONTAL MEDICINE  AN OVERVIEWPERIODONTAL MEDICINE  AN OVERVIEW
PERIODONTAL MEDICINE AN OVERVIEWPERIODONTAL MEDICINE AN OVERVIEW
SupriyoGhosh15
 
Heart in covid 19
Heart in covid 19Heart in covid 19
Heart in covid 19
gisa_legal
 

Similar to Periodontal medicine.pptx (20)

gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...
gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...
gpqfwg3jq2ymkj8xy5hy-signature-2c5a151fab12e21d70b85ccdc99aeddabbd0b614a36e4d...
 
Periodontal medicine
Periodontal medicinePeriodontal medicine
Periodontal medicine
 
DOC-20221116-WA0009..pptx
DOC-20221116-WA0009..pptxDOC-20221116-WA0009..pptx
DOC-20221116-WA0009..pptx
 
periodontal medicine.pptx
periodontal medicine.pptxperiodontal medicine.pptx
periodontal medicine.pptx
 
6. cvs
6. cvs6. cvs
6. cvs
 
PERIODONTAL MEDICINE 1.pptx DIABETES DIABE
PERIODONTAL MEDICINE 1.pptx DIABETES DIABEPERIODONTAL MEDICINE 1.pptx DIABETES DIABE
PERIODONTAL MEDICINE 1.pptx DIABETES DIABE
 
Periodontal Medicine: Impact of periodontal disease on systemic health
Periodontal Medicine: Impact of periodontal disease on systemic healthPeriodontal Medicine: Impact of periodontal disease on systemic health
Periodontal Medicine: Impact of periodontal disease on systemic health
 
Systemic disease and periodontal health..pptx
Systemic disease and periodontal health..pptxSystemic disease and periodontal health..pptx
Systemic disease and periodontal health..pptx
 
Coagulacion diseminada intravascular
Coagulacion diseminada intravascularCoagulacion diseminada intravascular
Coagulacion diseminada intravascular
 
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdfALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
 
Systemic Health and Periodontal Disease.pptx
Systemic Health and Periodontal Disease.pptxSystemic Health and Periodontal Disease.pptx
Systemic Health and Periodontal Disease.pptx
 
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptxPERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
 
Current approach in periodontal care
Current approach in periodontal careCurrent approach in periodontal care
Current approach in periodontal care
 
Periodontal diseases & cardiovascular system By Dr Sachin Rathod
Periodontal diseases & cardiovascular system By Dr Sachin RathodPeriodontal diseases & cardiovascular system By Dr Sachin Rathod
Periodontal diseases & cardiovascular system By Dr Sachin Rathod
 
ckd-23-1-1.pdf
ckd-23-1-1.pdfckd-23-1-1.pdf
ckd-23-1-1.pdf
 
2019 evolucion del estado de Sepsis en español.pdf
2019 evolucion del estado de Sepsis en español.pdf2019 evolucion del estado de Sepsis en español.pdf
2019 evolucion del estado de Sepsis en español.pdf
 
Nature ei
Nature   eiNature   ei
Nature ei
 
periodontal medicine A two-way street relationship between periodontal diseas...
periodontal medicine A two-way street relationship between periodontal diseas...periodontal medicine A two-way street relationship between periodontal diseas...
periodontal medicine A two-way street relationship between periodontal diseas...
 
PERIODONTAL MEDICINE AN OVERVIEWPERIODONTAL MEDICINE AN OVERVIEW
PERIODONTAL MEDICINE  AN OVERVIEWPERIODONTAL MEDICINE  AN OVERVIEWPERIODONTAL MEDICINE  AN OVERVIEWPERIODONTAL MEDICINE  AN OVERVIEW
PERIODONTAL MEDICINE AN OVERVIEWPERIODONTAL MEDICINE AN OVERVIEW
 
Heart in covid 19
Heart in covid 19Heart in covid 19
Heart in covid 19
 

More from DentalYoutube

Maxillary sinus.ppt
Maxillary sinus.pptMaxillary sinus.ppt
Maxillary sinus.ppt
DentalYoutube
 
Introduction to Dental Anatomy.ppt
Introduction to Dental Anatomy.pptIntroduction to Dental Anatomy.ppt
Introduction to Dental Anatomy.ppt
DentalYoutube
 
rationale of endodontic treatment.pptx
rationale of endodontic treatment.pptxrationale of endodontic treatment.pptx
rationale of endodontic treatment.pptx
DentalYoutube
 
diseasesofpulpandperiapicaltissues.pptx
diseasesofpulpandperiapicaltissues.pptxdiseasesofpulpandperiapicaltissues.pptx
diseasesofpulpandperiapicaltissues.pptx
DentalYoutube
 
cleaningandshaping.pptx
cleaningandshaping.pptxcleaningandshaping.pptx
cleaningandshaping.pptx
DentalYoutube
 
castrestorations-170210145741-converted.pptx
castrestorations-170210145741-converted.pptxcastrestorations-170210145741-converted.pptx
castrestorations-170210145741-converted.pptx
DentalYoutube
 
caseselectionfinal-170514163212.pptx
caseselectionfinal-170514163212.pptxcaseselectionfinal-170514163212.pptx
caseselectionfinal-170514163212.pptx
DentalYoutube
 
sealers.pptx
sealers.pptxsealers.pptx
sealers.pptx
DentalYoutube
 
MERCURY TOXICITY.pptx
MERCURY TOXICITY.pptxMERCURY TOXICITY.pptx
MERCURY TOXICITY.pptx
DentalYoutube
 
contactsandcontours.pptx
contactsandcontours.pptxcontactsandcontours.pptx
contactsandcontours.pptx
DentalYoutube
 
resorption-160714175024.pptx
resorption-160714175024.pptxresorption-160714175024.pptx
resorption-160714175024.pptx
DentalYoutube
 
pulpirritants.pptx
pulpirritants.pptxpulpirritants.pptx
pulpirritants.pptx
DentalYoutube
 
pulp responses.pptx
pulp responses.pptxpulp responses.pptx
pulp responses.pptx
DentalYoutube
 
NON CARIOUS LESIONS AND MANAGEMENT.pptx
NON CARIOUS LESIONS AND MANAGEMENT.pptxNON CARIOUS LESIONS AND MANAGEMENT.pptx
NON CARIOUS LESIONS AND MANAGEMENT.pptx
DentalYoutube
 
introduction-ENDODONTICS.pptx
introduction-ENDODONTICS.pptxintroduction-ENDODONTICS.pptx
introduction-ENDODONTICS.pptx
DentalYoutube
 
Intracanal Medicaments.pptx
Intracanal Medicaments.pptxIntracanal Medicaments.pptx
Intracanal Medicaments.pptx
DentalYoutube
 
cavity designs.pptx
cavity designs.pptxcavity designs.pptx
cavity designs.pptx
DentalYoutube
 
airabrasion.pptx
airabrasion.pptxairabrasion.pptx
airabrasion.pptx
DentalYoutube
 
PAIN CONTROL in operative dentistry.pptx
PAIN CONTROL in operative dentistry.pptxPAIN CONTROL in operative dentistry.pptx
PAIN CONTROL in operative dentistry.pptx
DentalYoutube
 

More from DentalYoutube (20)

Maxillary sinus.ppt
Maxillary sinus.pptMaxillary sinus.ppt
Maxillary sinus.ppt
 
Introduction to Dental Anatomy.ppt
Introduction to Dental Anatomy.pptIntroduction to Dental Anatomy.ppt
Introduction to Dental Anatomy.ppt
 
rationale of endodontic treatment.pptx
rationale of endodontic treatment.pptxrationale of endodontic treatment.pptx
rationale of endodontic treatment.pptx
 
diseasesofpulpandperiapicaltissues.pptx
diseasesofpulpandperiapicaltissues.pptxdiseasesofpulpandperiapicaltissues.pptx
diseasesofpulpandperiapicaltissues.pptx
 
cleaningandshaping.pptx
cleaningandshaping.pptxcleaningandshaping.pptx
cleaningandshaping.pptx
 
castrestorations-170210145741-converted.pptx
castrestorations-170210145741-converted.pptxcastrestorations-170210145741-converted.pptx
castrestorations-170210145741-converted.pptx
 
caseselectionfinal-170514163212.pptx
caseselectionfinal-170514163212.pptxcaseselectionfinal-170514163212.pptx
caseselectionfinal-170514163212.pptx
 
sealers.pptx
sealers.pptxsealers.pptx
sealers.pptx
 
MERCURY TOXICITY.pptx
MERCURY TOXICITY.pptxMERCURY TOXICITY.pptx
MERCURY TOXICITY.pptx
 
DFG.pptx
DFG.pptxDFG.pptx
DFG.pptx
 
contactsandcontours.pptx
contactsandcontours.pptxcontactsandcontours.pptx
contactsandcontours.pptx
 
resorption-160714175024.pptx
resorption-160714175024.pptxresorption-160714175024.pptx
resorption-160714175024.pptx
 
pulpirritants.pptx
pulpirritants.pptxpulpirritants.pptx
pulpirritants.pptx
 
pulp responses.pptx
pulp responses.pptxpulp responses.pptx
pulp responses.pptx
 
NON CARIOUS LESIONS AND MANAGEMENT.pptx
NON CARIOUS LESIONS AND MANAGEMENT.pptxNON CARIOUS LESIONS AND MANAGEMENT.pptx
NON CARIOUS LESIONS AND MANAGEMENT.pptx
 
introduction-ENDODONTICS.pptx
introduction-ENDODONTICS.pptxintroduction-ENDODONTICS.pptx
introduction-ENDODONTICS.pptx
 
Intracanal Medicaments.pptx
Intracanal Medicaments.pptxIntracanal Medicaments.pptx
Intracanal Medicaments.pptx
 
cavity designs.pptx
cavity designs.pptxcavity designs.pptx
cavity designs.pptx
 
airabrasion.pptx
airabrasion.pptxairabrasion.pptx
airabrasion.pptx
 
PAIN CONTROL in operative dentistry.pptx
PAIN CONTROL in operative dentistry.pptxPAIN CONTROL in operative dentistry.pptx
PAIN CONTROL in operative dentistry.pptx
 

Recently uploaded

Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 

Recently uploaded (20)

Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 

Periodontal medicine.pptx

  • 1. 1 PRESENTED BY DR ASIF K DEPARTMENT OF PERIODONTICS
  • 2.  Offenbacher 1996 defines periodontal medicine as a rapidly emerging branch of periodontology which focuses on the research of new data establishing a strong relationship between periodontal health or disease and systemic health or disease. 2
  • 3.  This means a two-way relationship in which periodontal disease in an individual may have a powerful influence on an individual’s systemic health or disease .  Non specific accumulation of bacterial plaque was once thought to be the cause of periodontal destruction, but now it is recognised that periodontitis is an infectious disease associated with predominantly gram negative bacteria.  Although pathogenic bacteria are necessary for periodontal disease, they are not sufficient alone to cause the disease. A susceptible host is also required. 3
  • 4.  There are many systemic conditions that can modify the host susceptibility to periodontitis.  Patients with immune suppression may not be able to mount effective host response to subgingival microorganisms, resulting in more rapid and severe attachment loss. 4
  • 5.  Although the potential impact of many systemic conditions on the periodontium is well documented, recent studies done by Seymour et al suggest that periodontal infection may significantly enhance the risk for certain systemic condition or alter the course of systemic condition. 5
  • 6.  Acc. To William Hunter in 1900, ◦ Oral microorganism- responsible for systemic conditions ◦ Restoration instead of extraction, trapping of infectious agents ◦ Gingivitis & periodontitis- foci of infection Connection between oral sepsis & resulting systemic condition could be shown by removal of causative sepsis through extraction & observation of improvement in systemic health 6
  • 7.  This theory fell into disrepute in 1940’s & 1950’s when widespread extraction failed to reduce or eliminate the systemic conditions to which the supposedly infected dentition has been linked. 7
  • 8.  Cardiovascular/ cerebrovascular system ◦ Atherosclerosis ◦ Coronary heart disease (CHD) ◦ Angina ◦ Myocardial infarction (MI) ◦ Cerebrovascular accident (stroke)  Endocrine system ◦ Diabetes mellitus 8
  • 9.  Reproductive system ◦ Preterm low birth weight infants ◦ Preeclampsia  Respiratory system ◦ Chronic obstructive pulmonary disease ◦ Acute bacterial pneumonia 9
  • 10.  Well known relationship  Study done by Matilla et al found that MI patients had significantly worse dental health than did the controls.  This association between poor dental health and MI was independent of the known risk factor for heart disease such as age, hypertension, chlosterol levels, diabetes.  Malthaner et al also found an increased risk of angiographically defined CAD in subjects showing greater attachment and bone loss.  However after adjusting for other risk factor for the CAD the relationship between the periodontal status and CAD was no longer significant. 10
  • 11.  Associated with atherogenesis & thrombogenesis 11
  • 12.  Increased viscosity of blood → increase risk of thrombus formation → ischemic heart disease & cerebrovascular accident  Factors affecting blood viscosity ◦ Plasma fibrinogen ◦ Plasma lipoproteins ◦ White blood cell count ◦ von Willebrand factor ◦ Increased plasma fibrinigen level is considered as risk factor for cardiovascular disease (Lowe et al). 12
  • 13. Systemic or periodontal infection ↑ Fibrinogen, ↑ White blood cell count ↑ von Willebrand factor ↑ Blood viscosity Ischemic heart disease 13
  • 14. Thrombogenesis 14  Platelet aggregation plays a major role in thrombogenesis .  Most cases of acute myocardial precipitated by thromboembolism  Oral organisms may be involved thrombogenesis infarction are in coronary
  • 15. Thromboembolism mechanism 15 Platelet binds – Streptococcus sanguis and P. gingivalis ↓ Platelet aggregation – Plalelet Aggregation Associated Protein ↓ Bacterial strains enters the circulation ↓ Forms thromboemboli ↓ Cardiac & pulmonary changes
  • 16.  It is a focal thickening of the arterial intima , the innermost layer lining the lumen of the vessel , and the arterial media, the thick layer under the arterial intima consisting of smooth muscle, collagen, and elastic fibres.  Occur in large & medium sized elastic & muscular arteries  Intimal lesion is called atheroma or atheromatous or fibro fatty plaques  Protrude into & obstruct vascular lumina 16
  • 17.  Periodontitis & atherosclerosis have many potential pathogenic mechanism in common  Both have Complex causation Genetic & gender predisposition Share many risk factors, most significant is smoking status  Periodontitis, which is a chronic inflammation initiated by microbial plaque can predispose to atherosclerosis. 17
  • 18. LPS released from microorganisms within the periodontal pocket- enter the diseased periodontium. Monocytes/ Macrophages adheres vascular endothelium Ingest circulating LDL & forms foam cell – atheromatous plaque Smooth muscle & collagen proliferation – arterial wall thickening Narrows lumen & ↓blood flow 18
  • 19. Figure showing pathogenesis of atherosclerosis 19
  • 20. Periodontal infection Gram- negative bacteremia/ LPS Endothelial damage, Platelet adhesion/ aggregation Monocyte infiltration/ proliferation Cytokine/ growth factor production Thrombus formation Atheroma formation Vessel wall thickening Thromboembolic events 20
  • 21. 21
  • 22. 1. Direct effects of infectious agents in atheroma formation 2. Indirect or host mediated effects triggered by infection 3. Common genetic predisposition for periodontal disease & atherosclerosis 4. Common risk factors such as life style
  • 23.  Direct effects of infectious agents in atheroma formation Studies done by Tonetti M et al, 2007 show Porphyromonas gingivalis is found in carotid and coronary atheromas. Deshpande and colleagues (1998) conducted a study and concluded that P. gingivalis can invade and may proliferate in the endothelial cells Herzberg and Meyer (1996) showing that P. gingivalis is able to induce aggregation of platelets, which is thought to be associated with thrombus formation.
  • 24. Indirect infection or host mediated effects triggered by Periodontitis induces an inflammatory response, production of acute-phase proteins, such as C-reactive protein and fibrinogen. C-reactive protein and fibrinogen are independent risk factors for coronary artery disease, hence if they are induced by periodontal infection, this may help explain the link between periodontal disease and heart disease.
  • 25.  A recent study by Wu and colleagues (1999) using the NHANES III database, found that C-reactive protein and plasma fibrinogen were related to poor periodontal health, which provides support for this hypothesis.
  • 26. Common genetic predisposition for periodontal disease & atherosclerosis Beck JD and colleagues (1996) have provided a model proposing that there is a genetically determined hyper inflammatory macrophage phenotype in periodontal disease, which for contributes to the susceptibility atherosclerosis
  • 27. Potential linkage mechanisms for periodontal disease & myocardial infarction Evidence for the role of inflammatory mediators C-reactive protein (CRP) Smooth muscle cells proximal to apoptotic cells in the arterial plaque produce secretory type II phospholipase which interacts with inverted phospholipid bilayer in the membrane of an apoptotic cell, thus preparing a nidus for CRP to bind. CRP induces local proinflammatory cytokine production & may bind complement either prior to tissue localisation or in situ, thereby enhancing removal of dying cell. Complement activation in turn may precipitate collateral damage. 27
  • 28. Tumor Necrosis Factor-α TNF-α has been shown to increase the synthesis of triglycerides in the liver and to inhibit lipoprotein lipase. This elevated levels of triglyceride rich glycoproteins and decreased levels of high density lipoprotein cholesterol has been associated with coronary heart disease. Also macrophages and smooth muscle cells expressing TNF –α are present in atherosclerotic plaques, suggesting its role in atherogenesis. 28
  • 29. Fibrinogen 29 •Fibrinogen is an acute phase protein mainly synthesized in the liver in response to IL-6. •Fibrinogen levels increase during infections and inflammatory conditions including Periodontitis. •IL-1 is considered as one of the important mediators in the pathogenesis of periodontal disease and both fibrinogen and fibrin can stimulate production of IL-1β and protein by binding to CD18 integrin receptors on normal human monocytes.
  • 30. ICAM-1 and VCAM-1 30 molecule-1(ICAM-1) and Intercellular adhesion vascular cell adhesion molecule-1 (VCAM-1) are important in the firm endothelial cell attachment and transendothelial migration of leucocytes, thus playing a central role in leucocyte recruitment and their function in inflammatory reactions. These molecules act as modulators of cell to cell interactions as activators of certain target cells and possibly, even as neutrophil chemoattractants. These soluble factors have been associated with various inflammatory conditions.
  • 31. Presence of systemic infection before stroke ↓ Greater ischemia & more severe post ischemic neurologic defect. Stroke patients with a preceding infection had a slightly higher levels of plasma fibrinogen & CRP than thosewithout infection 31
  • 32.  Syrjagen et al 1989, found a statistically significant poor level of oral health in patients with ischemic cerebral infarction as compared to controls.  Grau & colleagues 1997, reported that poor dental status was associated with cerebral ischemia.  Beck & colleagues 1996, provided first longitudinal data relating stroke to oral infections. They found that high mean alveolar bone loss was predictive of subsequent stroke. 32
  • 33.  Complex metabolic disorder characterised by chronic hyperglycemia.  Diminished insulin secretion, impaired insulin action or a combination of both result in the inability of glucose to be transported from the bloodstream into the tissues which in turn results in high blood glucose level.  Alteration in lipid or protein metabolism 33
  • 34. 1. Type 1 diabetes (insulin dependent) 2. Type 2 diabetes (non insulin dependent) 3. Gestational diabetes 4. Others ◦ Genetic defects in beta cell function ◦ Genetic defects in insulin action 34
  • 35. Food digestion ↓ ↑ blood glucose ↓ ↑ Insulin secretion ↓  Muscle increases uptake of glucose  Muscle & liver store glucose as glycogen  Liver prevents glycogen from breaking down into glucose ↓ ↓ blood glucose 35
  • 36. Type 1 diabetes Type 2 diabetes Age of onset Generally < 30 years Generally in adult hood Most common body type Thin or normal stature Obese Race White African American, American Indian Family history Common More common Rapidity of clinical onset Abrupt Slow Pathogenesis Autoimmune beta cell destruction Insulin resistance, impaired insulin secretion, increased liver glucose production Endogenous insulin production None Decreased, normal or elevated Susceptibility to ketoacidosis High Low Treatment may include Diet, exercise, insulin Diet, exercise, oral agents, insulin 36
  • 37.  It is clear from epidemiologic research that diabetes increases risk for & severity of periodontal disease.  The increased prevalence and severity of periodontitis typically seen in patients with diabetes, especially those with poor metabolic control led to the designation of periodontal disease as sixth complication of diabetes (Loe et al ). 37
  • 38.  Complications of diabetes mellitus 1. Retinopathy 2. Nephropathy 3. Neuropathy 4. Macrovascular disease 5. Altered wound healing 6. Periodontal disease 38
  • 39.  Taylor et al conducted a study amongst type 2 diabetes patients and concluded that severe periodontitis was associated with significant worsening of the glycemic control over time.  He concluded that individual with severe periodontitis at baseline examination were associated with a greater incidence of worsening glycemic control over a period of 2 to 4 years as compared to those without periodontitis at baseline examination.  Macrovascular complications were also found to be more amongst individual with severe periodontitis at baseline. 39
  • 40.  In diabetic patients with periodontitis, periodontal therapy may have beneficial effect on glycemic control.  This is true for patients with with relatively poor glycemic control and advanced periodontal destruction before treatment.  Hiltunen et al conducted a study amongst 65 subjects with type 1 diabetes and chronic periodontitis and found that although there was overall improvement in periodontal health after therapy , 35 % of subjects had an improvement in glycemic control after therapy, 37 % had no significant change and 28 % showed worsening of glycemic control. 40
  • 41. Effectsof periodontalinfection on glycemia 41 •Bacterial infections decrease insulin-mediated glucose uptake by skeletal muscle and produce whole-body insulin resistance. •Acute endotoxemia and cytokine production, mostly TNF-α and IL-lß, induce insulin resistance and decreased insulin action. •The insulin receptor tyrosine kinase, and the action of protein kinase C may, either individually or in combination, mediate some of the insulin effects such as translocation and activation of glucose-transporting proteins.
  • 42. •TNF-α has been suggested as the mediator of insulin resistance in infection by suppressing insulin induced tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), thus impairing insulin action. 42
  • 45.  Treatment with scaling & root planing, surgery, selected tooth extraction & systemic antibiotics resulted in decreased insulin demand.  Miller et al 1992, evaluated that scaling & root planing combined with systemic doxycycline therapy for 2 weeks, when given in type I diabetic patients with improved periodontal health also had significant improvement in glycemic control. 45
  • 46.  Tetracycline can also be given as tetracycline is known to suppress glycation of proteins & to decrease activity of tissue- degrading enzymes such as MMPs.  Diabetes is associated with greatly elevated production of collagenase, low dose doxycycline has been used in treatment of periodontitis in diabetic subjects.  Al-Ghazi et al 2003 & Engerbretson et al 2003, reported short term improvements in glycemic control with combination therapy, whereas no change was seen with mechanical therapy alone. 46
  • 47.  The international definition of low birth weight adopted by the Twenty-ninth World Health Assembly in 1976 is a birth weight of ‘‘less than 2500 g’’  Low birth weight can be as a result of both a short gestational period and retarded intrauterine growth. 47
  • 48.  Causes ◦ Preterm labor or premature rupture of membranes ◦ Smoking, alcohol or drugs use during pregnancy ◦ Inadequate prenatal care ◦ Race, low socioeconomic status ◦ Hypertension, diabetes ◦ High or low maternal age ◦ Genitourinary tract infection ◦ Maternal stress & genetic background ◦ Periodontal disease 48
  • 49.  Labor is characterized by coordinated uterine contractions leading to cervical dilatation, and finally expulsion of the fetus.  In term (‘‘normal’’) labor, rupture of the membranes occurs after initiation of contractions. 49
  • 50. •The earliest identified events in labor are increases in the bioavailability of prostaglandin E2, and in the concentration of receptors for the hormone oxytocin. •The increase in oxytocin receptors during labor induces the stretching of the cervix and myometrium which is thought to initiate a neurogenic reflex to the neurohypophysis of the pituitary gland, which acts as positive feedback for oxytocin production. 50
  • 51.  Remote gram- negative infection may play a role in LBW infants  Periodontopathic organisms & their products may mediate host cytokine production in target tissues.  Collins et al 1994, reported that P.gingivalis during gestation causes significant increase in TNF- a & PGE2. 51
  • 52.  Significant correlation between both TNF- a & PGE2 levels, as well as fetal death & growth retardation.  Collins et al also evaluated that there was decreased fetal birth weight & increased fetal death after intravenous injections with LPS derived from P.gingivalis.  Offenbacher et al 1996 found that women having LBW infants had greater clinical attachment loss than women having NBW infants. 52
  • 53.  In a cross sectional study, women having LBW infants had significantly higher levels of A.A, Bacteroides forsythus, P. gingivalis and Treponema denticola in their subgingival plaque.  Lopez et al 2002 found that women who received SRP before 28 weeks of gestation, followed by prophylaxis every 2 weeks until parturition, had a LBW rate of 1.8% as compare to women who did not receive periodontal therapy who had LBW rate of 10.1% 53
  • 54. •Periodontal infections, serve as reservoirs for Gram- negative anaerobic organisms, lipopolysaccharide (LPS, endotoxin), and inflammatory mediators. •Exposure to oral LPS down-regulates E-selectin expression on endothelial cells and thereby prevents the normal leukocytic margination and diapedesis which would occur in response to a secondary enteric LPS challenge. •This raises the possibility that systemic challenge with oral LPS may inhibit normal neutrophil clearance of enteric organisms that may permit a selective overgrowth or invasion of Gram-negative organism within the genitourinary tract. including PGE2 and TNF-α, may pose a potential threat to the fetal-placental unit. 54
  • 55. BacterialVaginosis 55 Caused by changes in the vaginal microflora in which normally predominant facultative lactobacilli are replaced by Gardnerella vaginalis; anaerobic organisms, including species of the genera Prevotella, Bacteroides, Peptostreptococcus, Porphyromonas, and others. Bacterial vaginosis is a known risk factor for preterm labor, premature rupture of membranes, and LBW. .
  • 56. The primary mechanism has traditionally been thought to be ascending infection from the vagina and endocervix. Endotoxin & bioactive enzymes by many organisms associated with vaginosis may directly injure tissue, as well as induce release of proinflammatory cytokines and prostaglandins. 56
  • 57. •Throughout normal gestation, amniotic prostaglandin levels rise steadily until a sufficient threshold is reached that induces labor and delivery. •Maternal infection may cause increased prostaglandin production and may result in labor- inducing levels being •achieved before full gestation •Various pro-inflammatory cytokines such as IL-1, IL-6, and TNF α have been found in the amniotic fluid of women with preterm labor. •Women with preterm labor often have culture-positive amniotic fluid, even in the absence of clinical infection. Of culture-positive patients, the most commonly isolated species is Fusobacterium nucleatum. 57
  • 58.  Airflow obstruction resulting from chronic bronchitis or emphysema.  Bronchial mucosal gland enlarge & inflammatory process occurs in which neutrophils & mononuclear inflammatory cells accumulate within the lung tissue. 58
  • 59.  Risk factors of COPD ◦ Cigarette smoking ◦ Genetic conditions  Presence of defective alpha-1 antitrypsin  Variant alpha-1 antichymotyrpsin  Alpha-2 macroglobulin  Vitamin D- binding protein 59
  • 60.  Share similar pathogenic process  Host inflammatory response mounted in response to chronic challenge ◦ By bacteria in periodontal disease ◦ By factors like cigarette smoke in COPD  Neutrophil influx → release of oxidative & hydrolytic enzymes → tissue destruction directly. 60
  • 61.  Recruitment of monocytes & macrophages leads to further release of proinflammatory cytokines.  Hayes et al (1998) found a positive correlation between advanced alveolar bone loss and COPD.  Scannapieco et al 1998, individuals with poor oral hygiene have been found to be at increased risk for chronic respiratory diseases such as bronchitis & emphysema. 61
  • 62.  Infection of the lungs caused by Bacteria Viruses Fungi Mycoplasma 62
  • 64.  Caused by ◦ Inhalation of infectious aerosol ◦ Aspiration of oropharyngeal organism  Streptococcus pneumoniae & H.influenzae  Antibiotic therapy is highly successful in resolution of the cases of community acquired pneumonia.  Till now no association between periodontal disease & community acquired pneumonia has been found 64
  • 65.  Nosocomial pneumonia  Gram- negative aerobic organism  Many cases by anaerobic bacteria, subgingival environment  It is usually caused by the aspiration of oropharyngeal contents, potential respiratory pathogens (PRPs) 65
  • 66.  Selective decontamination to eradicate PRPs- systemic antibiotics + orally administered nonabsorbable antibiotics  PRPs may also originate in oral cavity, dental plaque serve as a reservoir  Subgingival plaque harbor PRPs & periodontal pathogens, associated with nosocomial pneumonia. 66  Furthermore, anaerobic pocket may serve as respiratory diseases. organisms from a inoculum for periodontal suppurative
  • 67.  Scannapieco et al 2003, concluded that interventions used to improve oral hygiene, such as mechanical tooth brushing & chemical antimicrobials rinses, have a potential to decrease the risk of nosocomial pneumonia in high-risk patients, such as those in intensive care units or those on ventilators. 67
  • 68. 1. Oral pathogens may be aspirated into lung to cause infection 2. Periodontal disease- associated enzymes in saliva may modify mucosal surfaces to promote adhesion & colonization by respiratory pathogens 3. Periodontal disease- associated enzymes may destroy salivary pellicles on pathogenic bacteria 4. Cytokines originating from periodontal tissues may alter respiratory epithelium to promote infection by respiratory pathogens 68
  • 69.  Periodontal disease may affect the host’s susceptibility to systemic disease through subgingival biofilms, acting as reservoirs of Gram negative bacteria, transient bacteremia, release of microbial toxins & as a reservoir of inflammatory mediators.  More research is needed to these systemic diseases, & then develop appropriate interventions  More research is needed before recommendations can be made to treat periodontal disease as a strategy to prevent or treat CVD, diabetes mellitus, pre-term birth & other adverse pregnancy outcomes & also respiratory diseases. 70